Novartis Investor Presentation
New Novartis: Our strategy
Our focus
Core Therapeutic Areas
> Technology platforms
Priority geographies
Capital allocation / structure
Our priorities
Conclusion
Abbreviations
leveraging the strengths across our organization
Depth and breadth across
2+3 platforms
~70 projects¹
Technology
platforms
2. Technology platforms
Manufacturing scale and expertise
Europe
North Americas
Asia
1 Exploratory to Ph1/2
Development and
regulatory experience
를
11
Novartis Investor Presentation | September 22, 2022
ALL
ULBUL
0019
CAR
TO
>30 manufacturing sites globally
Strong supply chain delivering quality & safety
(100% YTD favorable HA inspections)
Meeting sustainability targets
Global
footprint
Commercialization expertise
KYMRIAH LEQVIO® PLUVICTO™
LUTATHERAⓇ
zolgensma LUXTURNA
U |
NOVARTIS | Reimagining MedicineView entire presentation